Sanofi receives FDA approval for Tzield in paediatric diabetes
Sanofi has received approval from the US Food and Drug Administration (FDA) for a supplemental biologic licence application for Tzield…
Sanofi has received approval from the US Food and Drug Administration (FDA) for a supplemental biologic licence application for Tzield…
AbbVie has tapped North Carolina as the location for a new $1.4bn manufacturing site as part of its $100bn US manufacturing pledge – adding another giant to the growing list…
Merck & Co (MSD) and Google Cloud have formed a multi-year partnership, investing up to $1bn, to advance agentic AI enterprise transformation. The collaboration aims to implement an agentic platform across…
The Centers for Medicare & Medicaid Services (CMS) has hit pause on its pilot programme designed to offer insurer-fronted access to cheaper weight loss medications, as some insurance companies decline…
Ray Therapeutics has secured $125m in a Series B funding round, as the gene therapy-focused biopharma eyes a breakout on the ophthalmology market. Through the oversubscribed round, which was led…
MSD (Merck & Co) has secured a US approval for its two-drug human immunodeficiency virus (HIV) combination therapy, Idvynso (doravirine/islatravir), as the company looks to secure a slice of the…
BioAegis Therapeutics has entered a strategic partnership with Prenosis to advance AI-driven precision medicine for inflammatory diseases. The collaboration will evaluate biomarkers and patient subgroups with improved responses to BioAegis’…